✦ LIBER ✦

Death to the bad guys: Targeting cancer via Apo2L/TRAIL

✍ Scribed by S. Bouralexis; D. M. Findlay; A. Evdokiou

Book ID: 106349296
Publisher: Springer
Year: 2005
Tongue: English
Weight: 259 KB
Volume: 10
Category: Article
ISSN: 1360-8185
DOI: 10.1007/s10495-005-6060-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Death-receptor O-glycosylation controls

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

✍ Wagner, Klaus W; Punnoose, Elizabeth A; Januario, Thomas; Lawrence, David A; Pit 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 567 KB

The histone deacetylase inhibitor, suber

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

✍ Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 958 KB

## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt